What is Coherence Neuro?
Coherence Neuro operates at the critical nexus of neurotechnology, neurobiology, and machine learning, aiming to fundamentally alter the landscape of cancer treatment. The company challenges the traditional, often invasive, paradigms of oncology—surgery, radiation, and chemotherapy—by introducing a more precise, technology-led methodology. By integrating complex biological data with sophisticated computational algorithms, Coherence Neuro seeks to improve both the quality and duration of life for patients. Its market position is defined by a commitment to shifting the clinical narrative, moving away from brutal interventions toward a model of precisely managed health outcomes that prioritize the emotional and physical well-being of the patient.
How much funding has Coherence Neuro raised?
Coherence Neuro has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Possible Ventures, XTAL Strategies, SmartGateVC, Artesian, and Blackbird Ventures
Key Investors in Coherence Neuro
Possible Ventures
A venture capital firm focused on backing ambitious founders building the future of technology and science.
XTAL Strategies
A strategic investment group specializing in high-growth technology sectors and innovative medical research.
SmartGateVC
A venture capital firm that supports early-stage technology companies with a focus on artificial intelligence and deep tech.
What's next for Coherence Neuro?
With the recent capital infusion, Coherence Neuro is poised to expand its clinical research footprint and refine its machine learning infrastructure. The strategic roadmap likely involves scaling its neurobiological research capabilities to validate its therapeutic models in broader clinical settings. As the company matures, the focus will shift toward establishing key partnerships within the medical technology ecosystem and navigating the regulatory pathways required for widespread adoption. This phase of development is critical for proving the efficacy of its technology, ensuring that the firm can effectively bridge the gap between groundbreaking laboratory research and real-world patient care, ultimately setting a new standard for precision medicine in the oncology sector.
See full Coherence Neuro company page
